TOP TIERMARKET NEWSWIRE
News & sentiment

MINK THERAPEUTICS IN (INKT) — News & AI sentiment

MINK THERAPEUTICS IN (INKT) news roundup. 12 stories in the past week, 19 over 30 days. Average 30-day sentiment is 56.4/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 1 sales totalling $73K — net selling of $73K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
12
avg sentiment 54.3/100
30d stories
19
avg sentiment 56.4/100
Insider net (90d)
$73K
0 buys · 1 sells
Congress (90d)
0
0 buys · 0 sells

INKT news in the last 24 hours, 7 days, 30 days and 90 days

How much INKT coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowINKT storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days1254.3/100INKT headlines →
Last 30 days1956.4/100INKT headlines →
Last 90 days2558/100INKT headlines →

Latest stories on INKT

3d ago
3d ago
3d ago
3d ago
3d ago
3d ago
3d ago
4d ago
4d ago
4d ago
4d ago
MiNK Therapeutics Q3 2026 Earnings Preview
Business Insider50 · neutralearnings
4d ago
Nov 6
Nov 6
MiNK Therapeutics stock initiated at buy by H.C. Wainwright
Investing.com Analyst Ratings63 · neutralanalyst
Nov 4
Nov 4
Nov 2
Nov 2
Oct 21
Oct 12
Oct 2
Oct 2
Oct 2
Sep 30
Sep 30
Open INKT in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →